Current Protein Identity:B3UEZ6
New Search
Difference tags compare only the current result set; every original PDB and assembly record remains separate.
Related-Structure Differences
Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.
| PDB Entry | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Experimental Method | Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 5VN3 Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b Deposited 2017-04-28 | Assembly 1 Other combination Heteromer;Protein × 15 PDB declaration: pentadecameric(15) Consistent with protein count |
Chain A
516–668(153 aa)
Chain B
516–668(153 aa)
Chain D
516–668(153 aa)
|
Mutation:I559P, T605C Mutation:I559P, T605C Mutation:I559P, T605C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4;DDM was added to a final concentration of 0.06 mM prior to vitrification
cryo-EM vitrification conditions
Cryogen ETHANE;3 uL of sample applied to a holey carbon grid on glow discharged face and blotted manually on sample side until filter paper detached from grid, followed by immediate plunging
|
Resolution 3.70 Å |
| 5VN8 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 Deposited 2017-04-28 | Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count |
Chain A
516–668(153 aa)
Chain B
516–668(153 aa)
Chain C
516–668(153 aa)
|
Mutation:I559P, T605C Mutation:I559P, T605C Mutation:I559P, T605C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4;DDM was added to a final concentration of 0.06 mM prior to vitrification
cryo-EM vitrification conditions
Cryogen ETHANE;3 uL of sample applied to a holey carbon grid on glow discharged face and blotted manually on sample side until filter paper detached from grid, followed by immediate plunging
|
Resolution 3.60 Å |
| 6CH9 Crystal structure of a natively-glycosylated B41 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 Deposited 2018-02-22 | Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count |
Chain B
516–668(153 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;5% Tacismate pH 8.0, 15% PEG 3350
|
Resolution 4.85 Å R-free 0.292 |
| 6EDU B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Deposited 2018-08-11 | Assembly 1 Other combination Heteromer;Protein × 21 PDB declaration: 21-meric(21) Consistent with protein count |
Chain A
516–668(153 aa)
Chain B
516–668(153 aa)
Chain C
516–668(153 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 27 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.06 Å |
| 6MUF Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom Deposited 2018-10-23 | Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count |
Chain B
516–668(153 aa)
Fragment:gp41
|
Mutation:I559P, A605C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 | X-RAY DIFFRACTION |
X-ray crystallization conditions
EVAPORATION;298 K;90mM Na Acetate pH5.5
6% PEG8,000
3% PEG400
450mM NaCl
|
Resolution 2.91 Å R-free 0.297 |
| 6MUG Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom Deposited 2018-10-23 | Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count |
Chain B
516–668(153 aa)
Fragment:gp41
|
Mutation:I559P, A605C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 42 JYS 1-[4-(benzenecarbonyl)piperazin-1-yl]-2-(4-bromo-7-fluoro-1H-indol-3-yl)ethane-1,2-dione × 3 | X-RAY DIFFRACTION |
X-ray crystallization conditions
EVAPORATION;298 K;60mM Na Acetate pH5.5
4% PEG8,000
2%PEG400
300mM NaCl
|
Resolution 2.95 Å R-free 0.289 |
| 6OKP B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Deposited 2019-04-14 | Assembly 1 Other combination Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count |
Chain A
516–668(153 aa)
Fragment:UNP residues 516-668
Chain B
516–668(153 aa)
Fragment:UNP residues 516-668
Chain C
516–668(153 aa)
Fragment:UNP residues 516-668
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE;0 blot force, 3 second blot time, 3 uL sample added to freshly glow-discharged grids
|
Resolution 3.28 Å |
| 6OPN CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 Deposited 2019-04-25 | Assembly 1 Other combination Heteromer;Protein × 9 PDB declaration: nonameric(9) Consistent with protein count |
Chain B
516–668(153 aa)
Chain E
516–668(153 aa)
Chain H
516–668(153 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 27 N07 [3'-(5-methyl-1,3,4-oxadiazol-2-yl)[1,1'-biphenyl]-3-yl](piperidin-1-yl)methanone × 3 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4;Detergent (LMNG) added shortly (<5 minutes) prior to grid freezing using an 8X concentrated stock.
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å |
| 6OPO Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM Deposited 2019-04-25 | Assembly 1 Other combination Heteromer;Protein × 15 PDB declaration: pentadecameric(15) Consistent with protein count |
Chain B
516–668(153 aa)
Chain F
516–668(153 aa)
Chain M
516–668(153 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 LMT DODECYL-BETA-D-MALTOSIDE × 3 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4;DDM added shortly (<5 minutes) prior to freezing.
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å |
| 6OPP Asymmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM Deposited 2019-04-25 | Assembly 1 Other combination Heteromer;Protein × 15 PDB declaration: pentadecameric(15) Consistent with protein count |
Chain B
516–668(153 aa)
Chain E
516–668(153 aa)
Chain K
516–668(153 aa)
|
Not recorded | LMT DODECYL-BETA-D-MALTOSIDE × 3 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4;Detergent added shortly (<5 minutes) prior to grid freezing
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.70 Å |
| 6OPQ CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG Deposited 2019-04-25 | Assembly 1 Other combination Heteromer;Protein × 15 PDB declaration: pentadecameric(15) Consistent with protein count |
Chain B
516–668(153 aa)
Chain F
516–668(153 aa)
Chain G
516–668(153 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4;Detergent (LMNG) added shortly (<5 minutes) prior to grid freezing using an 8X concentrated stock.
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.80 Å |
| 6U59 HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B Deposited 2019-08-27 | Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count |
Chain B
516–668(153 aa)
Chain D
516–668(153 aa)
Chain I
516–668(153 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 30 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4;Detergent was added to sample shortly prior to freezing.
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.86 Å |
| 6X5B Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 Deposited 2020-05-25 | Assembly 1 Other combination Heteromer;Protein × 15 PDB declaration: pentadecameric(15) Consistent with protein count |
Chain B
516–668(153 aa)
Chain E
516–668(153 aa)
Chain K
516–668(153 aa)
|
Mutation:I559P, T605C Mutation:I559P, T605C Mutation:I559P, T605C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 27 UOV N-(4'-methyl[1,1'-biphenyl]-4-yl)-1-oxa-7-azaspiro[3.5]nonane-7-carboxamide × 3 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4;Detergent diluted into sample shortly before application to grid
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å |
| 6X5C Asymmetric model of CD4-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 Deposited 2020-05-25 | Assembly 1 Other combination Heteromer;Protein × 9 PDB declaration: nonameric(9) Consistent with protein count |
Chain B
516–668(153 aa)
Chain F
516–668(153 aa)
Chain G
516–668(153 aa)
|
Mutation:I559P, T605C Mutation:I559P, T605C Mutation:I559P, T605C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 23 UOV N-(4'-methyl[1,1'-biphenyl]-4-yl)-1-oxa-7-azaspiro[3.5]nonane-7-carboxamide × 3 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4;Detergent diluted into sample shortly before application to grid
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.04 Å |
| 8D5C anti-HIV-1 gp120-sCD4 complex antibody CG10 Fab in complex with B41-sCD4 Deposited 2022-06-04 | Assembly 1 Protein heterocomplex Heteromer;Protein × 15 PDB declaration: pentadecameric(15) Consistent with protein count |
Chain X
516–668(153 aa)
Chain Y
516–668(153 aa)
Chain Z
516–668(153 aa)
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.90 Å |